Molecular Cancer Therapeutics Funding
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Molecular Cancer Therapeutics 5, -, , . doi:
© 2008 American Association for Cancer Research
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Mol Cancer Ther García-Morales et al. 5: 2172

Supplementary Data, Garcia-Morales et al

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online